1. Home
  2. AGIO vs ARCO Comparison

AGIO vs ARCO Comparison

Compare AGIO & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ARCO
  • Stock Information
  • Founded
  • AGIO 2007
  • ARCO 2007
  • Country
  • AGIO United States
  • ARCO Uruguay
  • Employees
  • AGIO N/A
  • ARCO N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ARCO Restaurants
  • Sector
  • AGIO Health Care
  • ARCO Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • ARCO Nasdaq
  • Market Cap
  • AGIO 1.4B
  • ARCO 1.6B
  • IPO Year
  • AGIO 2013
  • ARCO 2011
  • Fundamental
  • Price
  • AGIO $33.97
  • ARCO $7.93
  • Analyst Decision
  • AGIO Buy
  • ARCO Buy
  • Analyst Count
  • AGIO 6
  • ARCO 1
  • Target Price
  • AGIO $58.60
  • ARCO $12.00
  • AVG Volume (30 Days)
  • AGIO 529.1K
  • ARCO 1.4M
  • Earning Date
  • AGIO 07-31-2025
  • ARCO 08-13-2025
  • Dividend Yield
  • AGIO N/A
  • ARCO 3.03%
  • EPS Growth
  • AGIO N/A
  • ARCO N/A
  • EPS
  • AGIO 11.45
  • ARCO 0.64
  • Revenue
  • AGIO $37,035,000.00
  • ARCO $4,465,398,000.00
  • Revenue This Year
  • AGIO $22.30
  • ARCO $7.11
  • Revenue Next Year
  • AGIO $219.19
  • ARCO $8.15
  • P/E Ratio
  • AGIO $3.00
  • ARCO $12.39
  • Revenue Growth
  • AGIO 25.96
  • ARCO 0.97
  • 52 Week Low
  • AGIO $23.42
  • ARCO $6.66
  • 52 Week High
  • AGIO $62.58
  • ARCO $10.55
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 52.40
  • ARCO 64.00
  • Support Level
  • AGIO $32.53
  • ARCO $7.61
  • Resistance Level
  • AGIO $34.34
  • ARCO $7.81
  • Average True Range (ATR)
  • AGIO 1.28
  • ARCO 0.15
  • MACD
  • AGIO -0.31
  • ARCO 0.04
  • Stochastic Oscillator
  • AGIO 20.98
  • ARCO 99.06

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.

Share on Social Networks: